Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$482,223.00
Dec 1, 2021
Individual or sole proprietorship
Gaps & Priorities (July 2021) - Immune Responses
163333
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$200,800.00
Dec 1, 2021
Individual or sole proprietorship
.: Emerging COVID Res. Gaps & Priorities - Indigenous Health Research
163267
The specific objectives of this funding opportunity are:
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$492,077.00
Dec 1, 2021
Individual or sole proprietorship
Team Grant: Indigenous Gender and Wellness Team Grant
163156
The specific objectives of this funding opportunity are to:
Support Indigenous-led research related to gender and wellness;
Encourage knowledge creation that will raise awareness and improve understanding of Indigenous concepts of gender in a strengths-based, wellness context;
Facilitate knowledge sharing as to how Indigenous concepts of gender can affect wellness, in a manner that is directly relevant to and for the benefit of Indigenous communities; and
Support the implementation of action-oriented, community-based projects that will improve wellness among Indigenous communities from a gendered perspective.
$484,409.00
Dec 1, 2021
Individual or sole proprietorship
Team Grant: Indigenous Gender and Wellness Team Grant
163150
The specific objectives of this funding opportunity are to:
Support Indigenous-led research related to gender and wellness;
Encourage knowledge creation that will raise awareness and improve understanding of Indigenous concepts of gender in a strengths-based, wellness context;
Facilitate knowledge sharing as to how Indigenous concepts of gender can affect wellness, in a manner that is directly relevant to and for the benefit of Indigenous communities; and
Support the implementation of action-oriented, community-based projects that will improve wellness among Indigenous communities from a gendered perspective.
$35,000.00
Dec 1, 2021
Individual or sole proprietorship
Team Gr: Diabetes Prevention & Treatment in Indigenous Communities: R&W - LOI
163087
The specific objectives of this funding opportunity are:
To define and integrate models of resilience and wellness into diabetes prevention and treatment approaches among First Nations, Inuit and Métis Peoples.
To support Indigenous-led and community-driven efforts to reverse the upward trajectory of diabetes in Indigenous communities.
$313,804.00
Dec 1, 2021
Individual or sole proprietorship
Gaps & Priorities (July 2021) - Urban Populations
163300
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$471,146.00
Dec 1, 2021
Individual or sole proprietorship
COVID-19 Res. Gaps & Priorities - Healthcare Resource Allocation
163303
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$449,926.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emer. COVID Res. Gaps/Priorities-Core Public Health and Control Measures
163271
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$469,235.00
Dec 1, 2021
Individual or sole proprietorship
COVID Res. Gaps/Priorities - Vaccine Distribution Models
163274
The specific objectives of this funding opportunity are:
a. Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults). Across all populations, researchers are encouraged to consider a lifecycle approach (from preconception to older adulthood).
$234,849.00
Dec 1, 2021
Individual or sole proprietorship
Operating Grant: Joint Programme on Neurodegenerative Disease Research (JPND)
162866
The specific objective of this funding opportunity is:
to establish a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that aim at identifying and measuring physiological effects and related biomarkers that can be linked to the development of neurodegenerative diseases, as well as enhancing the understanding of causal underlying cellular, molecular, metabolic, inflammatory or other systemic processes.